SRTSSensus Healthcare, Inc.

Nasdaq sensushealthcare.com


$ 5.32 $ -0.30 (-5.43 %)    

Tuesday, 14-May-2024 15:59:44 EDT
QQQ $ 446.00 $ 1.22 (0.27 %)
DIA $ 395.58 $ 0.49 (0.12 %)
SPY $ 523.36 $ 1.10 (0.21 %)
TLT $ 90.86 $ 0.25 (0.27 %)
GLD $ 218.12 $ 0.29 (0.13 %)
$ 5.4
$ 5.62
$ 3.00 x 2,000
$ 0.00 x 0
$ 5.24 - $ 5.62
$ 1.79 - $ 5.85
2,250,825
na
88.12M
$ 1.11
$ 19.11
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-05-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-06-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-10-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-sensus-healthcare-raises-price-target-to-10

HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target fro...

 maxim-group-maintains-buy-on-sensus-healthcare-raises-price-target-to-10

Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $...

 sensus-healthcare-q1-2024-gaap-eps-014-beats-006-estimate-sales-10663m-beat-4120m-estimate

Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0...

 largest-veterinary-emergency-hospital-in-tel-aviv-acquires-sensus-healthcares-srt-100-to-provide-gentler-radiotherapy-to-treat-tumors-in-dogs-and-cats-no-financial-terms-disclosed

First veterinary commercial sale of the SRT-100 outside the U.S.BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healt...

 sensus-healthcare-announces-sale-of-first-srt-100-vision-system-to-asia-no-financial-terms-disclosed

Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for b...

 sensus-healthcare-q4-2023-gaap-eps-026-beats-012-estimate-sales-1257m-beat-1106m-estimate

Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0....

 earnings-scheduled-for-february-8-2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

 sensus-healthcare-collaborates-with-curerays-curerays-to-provide-sensus-dermatology-customers-oversight-and-supervision-will-research-new-indications-for-sensus-superficial-radiotherapy

Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammat...

 why-3m-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-q...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION